Release Date: October 31, 2025
Expiration Date: October 31, 2026
Activity Overview
This video-based program is designed for health care professionals to explore recent advances in the management of patients with thymidine kinase 2 deficiency (TK2d). This online activity focuses on the pathophysiology, diagnosis, and management of TK2d. Further, data regarding investigational agents that may be game changers for the treatment of this disease are reviewed. The expert faculty discuss many of the issues facing clinicians who care for patients with TK2d.
Target Audience
These educational activities are directed toward pediatric neurologists, neurologists, genetic counselors, specialty NPs/PAs, RNs, pediatricians, and other HCPs who may encounter TK2d.
Learning Objectives
Upon completion of this educational activity, learners should be able to:
- Describe the relationship between the pathophysiological pathways underlying TK2d and its clinical presentations
- Implement diagnostic strategies to identify patients with TK2d
- Review the limitations of current treatment paradigms for patients with TK2d
- Evaluate clinical trial data for agents for TK2d
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here